GRI Bio Presents Preclinical Data Highlighting GRI-0621's Ability To Inhibit Invariant Natural Killer T Cell Activity

Benzinga · 10/16 12:49

Data suggest that NKT cells are activated in airways in Idiopathic Pulmonary Fibrosis (IPF) patients and inhibition of iNKT cell activity can treat bleomycin-induced pulmonary fibrosis

 

Company advancing Phase 2a biomarker study of GRI-0621 in patients with IPF with interim data expected Q4 2024 and topline data in Q1 2025

Data presented at the 22nd International Colloquium on Lung and Air